CytomX Therapeutics
CTMX
CTMX
83 hedge funds and large institutions have $303M invested in CytomX Therapeutics in 2025 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
+17
Holders Change %
+25.76%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
26
Reduced
17
Closed
12
Calls
$2.09M
Puts
$362K
Net Calls
+$1.73M
Net Calls Change
+$1.75M
Top Buyers
| 1 |
VA
VR Adviser
New York
|
+$31.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$20.7M |
| 3 |
O
OrbiMed
New York
|
+$19.2M |
| 4 |
CC
Commodore Capital
New York
|
+$17.5M |
| 5 |
PA
Perceptive Advisors
New York
|
+$15.9M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$5.89M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$3.81M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$3.32M |
| 4 |
CPC
Congress Park Capital
Saratoga Springs,
New York
|
-$1.31M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.04M |
